Efficacy of penicillin vs. amoxicillin in children with group A beta hemolytic streptococcal tonsillopharyngitis

Clinical Pediatrics

Volumn 42, Issue 3, 2003, Pages 219-225

  Curtin Wirt, Correne ^a   Casey, Janet R ^a   Murray, Patrick C ^a   Cleary, Carolyn T ^a   Hoeger, William J ^a   Marsocci, Steven M ^a   Murphy, Marie Lynd ^a   Francis, Anne B ^a   Pichichero, Michael E ^a,b  

^a Elmwood Pediatric Group   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; PENICILLIN V;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATION; OPEN STUDY; PATIENT COMPLIANCE; PHARYNGITIS; PROSPECTIVE STUDY; STREPTOCOCCUS GROUP A; THROAT CULTURE; TONSILLITIS; TREATMENT OUTCOME;

EID: 0037391405     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280304200305     Document Type: Article

References (47)

1. Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal illness. Comparison of lincomycin, ampicillin, and potassium penicillin G in treatment. Am J Dis Child. 1966;112:21-27.
2. Strom J. A comparison of the effects and side-effects of penicillin V and ampicillin in treatment of scarlet fever. Acta Paediatr Scand. 1968;57:285-288.
3. Stillerman M, Isenberg HD, Moody M. Streptococcal pharyngitis therapy. Comparison of cephalexin, phenoxymethyl penicillin, and ampicillin. Am J Dis Child. 1972;123:457-461.
4. Stillerman M, Isenberg HD, Facklam RR. Treatment of pharyngitis associated with group A streptococcus: comparison of amoxicillin and potassium phenoxymethyl penicillin. J Infect Dis. 1974;129:S169-177.
5. Breese BB, Disney FA, Talpey WB, Green JL. Treatment of streptococcal pharyngitis with amoxicillin. J Infect Dis. 1974;129(Suppl):S178-180.
6. Breese BB, Disney FA, Green, JL, Talpey WB. The treatment of beta hemolytic streptococcal pharygitis. Comparison of amoxicillin, crythromycin estolate, and penicillin V. Clin Pediatr. 1977;16:460-463.
7. Breese BB, Disney FA, Talpey WB. Penicillin in streptococcal infections: total dose and frequency of administration. Am J Dis Child. 1965;110:125-130.
8. Gerber MA, Randolph MF, DeMeo K, et al. Failure of once-daily penicillin V therapy for streptococcal pharyngitis. Am J Dis Child. 1989;143:153-155.
9. Krober MS, Weir MR, Themelis NJ, van Hamont JE. Optimal dosing interval for penicillin treatment of streptococcal pharyngitis. Clin Pediatr. 1990;29:646-648.
10. Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of streptococcal pharyngitis with amoxicillin once a day. BMJ. 1993;306:1170-1172.
11. Feder HM Jr, Gerber MA, Randolph MF, et al. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics. 1999;103(1):47-51.
12. Denny FW, Wannamaker LM, Brink WR, et al. Prevention of rheumatic fever: treatment of the preceding streptococcic infection. JAMA. 1950;142:151-153.
13. Wannamaker LW, Rammelkemp CR Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med. 1951;10:673-695.
14. Wannamaker LW, Denny FW, Perry WD, et al. The effect of penicillin prophylaxis on streptococcal disease rates and the carrier state. N Engl J Med. 1953;249:1-7.
15. Breese BB. Treatment of beta hemolytic streptococcic infections in the home. Relative value of available methods. JAMA. 1953;152:10-14.
16. Edmond EW, Cramblett HG, Siewers CM, et al. Comparison of efficacy of phenoxymethylpenicillin and buffered penicillin G in treatment of streptococcal pharyngitis. J Pediatr. 1966;68:442-447.
17. Gerber MA, Randolph MF, Chanatry J, et al. Five vs ten days of penicillin V therapy for streptococcal pharyngitis. Am J Dis Child. 1987;141:224-227.
18. Shvartzman H, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ. 1993;306:1170-1172.
19. Schwartz RH, Wientzen RL Jr, Pedreira F, et al. Penicillin V for group V streptococcal pharyngitis. A randomized trial of seven vs ten day's therapy. JAMA. 1981;246:1790-1795.
20. Stromberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis. 1988;20:37-46.
21. Peyramond D, Portier H, Geslin P, Cohen R, and the French Study Group Clamorange. 6-Day amoxicillin versus 10-day penicillin V for group A β-haemolytic streptococcal acute tonsillitis in adults: a french multicentre, open-label, randomized study. Scand J Infect Dis. 1996;28:497-501.
22. Cohen R, Levy C, Doit C, et al. Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 1996;15:678-682.
23. Pichichero ME, Green JL, Francis AB, et al. Recurrent group A streptoccal tonsillopharyngitis. Pediatr Infect Dis J. 1998;17:809-815.
24. Betriu C, Sanchez A, Gomez M, et al. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother. 1993; 37:1717-1719.
25. Brook I. β-lactamase-producing bacteria recovered after clinical failures with various penicillin therapy. Arch Otolaryngol. 1984;110:228-231.
26. Brook I. The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984;6:601-607.
27. Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993;12:268-274.
28. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J. 1991;10:275-281.
29. Brook I, Gilmore JD. Evaluation of bacterial interference and β-lactamase production in management of experimental infection with group A beta-hemolytic streptococci. Antimicrob Agents Chemother. 1993;37:1452-1455.
30. Grahn E, Holm SE. Bacterial interference in the throat flora during streptococcal tonsillitis outbreak in an apartment house area. Zbl Bakt Mikrobio Hyg. 1983;256:72-79.
31. Grahn E, Holm SE, Ekedahl C, Roos K. Interference of α-hemolytic streptococci isolated from tonsillar surface on β-hemolytic streptococci (Streptococcus pyogenes). A methodological study. Zbl Bakt Hyg. 1983;254:459-468.
32. Roos K, Grahn E, Holm SE. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis. 1986;18:313-319.
33. Roos K, Grahn E, Holm SE, et al. Interfering streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol. 1993;25:141-148.
34. Sanders E. Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci. J Infect Dis. 1969;120:698-707.
35. Stjerniquist-Desatnik A, Samuelsson P, Walder M. Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. J Laryngol Otol. 1993;107:309-312.
36. Disney FA, Hanfling MJ, Hausinger SA, Loracarbef. (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis. Pediatr Infect Dis J. 1992;11(8 Suppl): S20-26.
37. Block SL, Hedrick JA, Tyler RD. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J. 1992;11(11):919-925.
38. Dajani AS, Kessler SL, Mendelson R, et al. Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis. Pediatr Infect Dis J. 1993;12(4):275-279.
39. Gooch WM III, McLinn SE, Aronovitz GH, et al. Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis. Antimicrob Agents Chemother. 1993;37(2):159-163.
40. McCarty JM. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis. Eur J Clin Microbiol Infect Dis. 1994;13(10):846-850.
41. Holm S, Henning C, Grahn E, et al. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Scand J Infect Dis. 1995;27(3):221-228.
42. Pichichero ME, McLinn SE, Gooch WM III, et al. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Member of the Ceftibuten Pharyngitis International Study Group. Pediatr Infect Dis J. 1995;14(7 Suppl):S102-107.
43. Roos K, Larsson P. Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis. Scand J Infect Dis. 1997;29(2):141-145.
44. Nemeth MA, McCarty J, Gooch WM III, et al. Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Cefdinir Pharyngitis Study Group. Clin Ther. 1999; 21(11):1873-1881.
45. Pichichero ME, Hoeger W, Marsocci SM, et al. Variables influencing penicillin treatment outcome in streptococcal tonsillopharyngitis. Arch Pediatr Adolesc Med. 1999;153:565-570.
46. Hofer C, Binns HJ, Tanz RR. Strategies for managing group A streptococcal pharyngitis. A survey of boardcertified pediatricians. Arch Pediatr Adolesc Med. 1997;151:824-829.
47. Steele RW, Estrada B, Begue RE, et al. A double-blind taste comparison of pediatric antibiotic suspensions. Clin Pediatr. 1997;36(4):193-199.